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Abstract 
Purpose: To investigate the protective effect of corynoline isolated from Corydalis bungeana Turcz on 
lipopolysaccharides (LPS)-induced sepsis, and determine the possible mechanism of anti-sepsis effect 
of the isolated corynoline.  
Methods: Corynoline was extracted by column chromatography. LPS (100 ng/mL) was used to induce 
the release of TNF-α and IL-6 in RAW 264.7 cells, and the isolated corynoline was added. ELISA 
method was used to determine the levels of TNF-α and IL- 6. Furthermore, sepsis in mice was 
established by injection of LPS (2 mg/kg, i.v.), and the levels of TNF-α and IL-6 in plasma were 
determined by ELISA method. For survival rate test, LPS (15 mg/kg, i.v.) and heat-killed E. coli (1.0 
×1011 CFU/kg, i.v.) were used to establish sepsis in mice model, and the mice were observed in 7 days.  
Results: The results indicate that corynoline significantly elevated the survival rate of septic mice 
induced by LPS and heat-killed E. coli, in a dose-dependent manner (p < 0.05). Corynoline decreased 
the release of TNF-α and IL-6 induced by LPS, in a dose-dependent manner (p < 0.05). 
Conclusion: Treatment with corynoline significantly inhibits the mortality of LPS-induced septic mice, 
and the mechanism of action is probably related to the decrease of TNF-α and IL-6 release. Thus 
corynoline has the potential to be developed as an effective and safe drug for treating sepsis. 
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Sepsis, defined as the harmful or damaged 
systemic host response to infection induced by 
microorganisms, is a life-threatening disorder [1]. 
The incidence of sepsis has significantly 
increased over the last ten years, and remains a 
serious clinical problem [2,3]. Sepsis is a severe 
clinical syndrome with high mortality (ranges 
from 30% to 50%), resulting in multiple organ 
damage, multiple organ dysfunction syndrome 
(MODS), and septic shock [4,5]. Although major 
advances have been made in diagnosis and 
pathogenesis of sepsis, no satisfactory therapy 
has emerged. Therefore, it is imperative and 
urgent to find an effective therapy for the 
treatment or alleviation of sepsis. 
 
Corydalis bungeana Turcz, which belongs to the 
Papaveraceae family, is a perennial herb found 
in many parts of the world, and has been 
traditionally used to treat inflammation, upper 
respiratory tract infections and influenza [6-7]. 
Corynoline is one of the major alkaloids of C. 
bungeana, and also has wide spectrum 
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pharmacological activities, such as anti-
inflamation, sedative, anti-leptospira, and 
hepatoprotective. [8-9]. However, thus far there 
have been no reports on the effects of corynoline 
on LPS-induced sepsis in mice and its possible 
mechanisms of action.  
 
In the present work, a large quantity of corynoline 
had been isolated from C. bungeana, and 
evaluated for is protective effects in LPS-induced 
sepsis in mice in order to determine a scientific 
basis, if any, for future application of corynoline 






Corydalis bungeana Turcz was purchased from 
the Tong-ren-tang Pharmaceutical Group and 
identified as the whole plant of C. bungeana by 
Professor Pingfei Fang, Department of 
Traditional Chinese Medicine, the Second 
Xiangya Hospital of Central South University, 
Changsha, China. A voucher specimen 
(S20120306#) was kept in the herbarium of 
Department of Traditional Chinese Medicine, the 
Second Xiangya Hospital of Central South 
University.  
 
Experimental animals  
 
Institute of Cancer Research (ICR) mice (20 ± 2 
g) were kept on a 12 h light/dark cycle with free 
access to standard laboratory chow and water. 
Humidity was maintained at 50 % and the 
temperature at 25 °C. Each animal was used 
only once in the experiment. The experimental 
protocols were approved by the Animal Care and 
Use Committee of the Central South University 
(no. 2012-2769). The animals were handled 
according to the standard protocols for the use of 




Silica-gel was purchased from Qingdao Haiyang 
Chemical Co, Ltd (Qingdao, China).The DMEM 
and FBS were purchased from Invitrogen 
(Carlsbad, USA). Fibronectin and 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) and LPS were obtained from 
Sigma (St. Louis, USA). All other chemicals used 
in this study were of analytical reagent grade. 
Mouse TNF-α and IL-6 ELISA kits were 
purchased from Biosource International 
(Camarillo, CA, USA). 
 
Preparation of corynoline from C. bungeana 
 
The dried and powdered whole plant of C. 
bungeana (20 kg) was extracted trice under 
reflux (each extraction period lasted 2 h) with 70 
% EtOH. The concentrated extract was dissolved 
in 2 % HCl (pH 3.5) and partitioned with ether. 
The pH of the aqueous solution was re-adjusted 
with ammonia water to 9.0 and extracted with 
CHCl3. The CHCl3 extract was chromatographed 
on silica gel (100-200 mesh) using CHCl3/MeOH 
solvent system of increasing polarity (20:1, 15:1, 
10:1, 5:1, and 2:1) as eluent to obtain five 
fractions A-E. Fraction C was further separated 
by repeated silica gel (200 -3 00 mesh) column 
chromatography, and eluted with cyclohexane / 
acetone, the yield was 3.2 g corynoline. 
 
Characterization of corynoline by nuclear 
magnetic resonance (NMR)  
 
The isolated chemical compound was identified 
by NMR. The NMR spectra were recorded on a 
Bruker AVANCE-600 MHz with TMS as internal 
standard and CDCl3 as solvents. 
 
Cell culture and cell viability assay 
 
The RAW264.7 cells, a murine macrophage cell 
line, were cultured in plastic dishes containing 
Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10 % heat-inactivated fetal 
bovine serum (FBS). The RAW 264.7 cells were 
plated at a density of 4 × 105 and pre-incubated 
for 24 h in a CO2 incubator (5 % CO2) at 37 °C. 
Then RAW264.7 cells were cultured with 
Corynoline (0, 10, 20, 40, 80, 160, 320 μg/mL) in 
the presence of 100 ng/mL lipopolysaccharide 
(LPS) for 24 h at 37 °C. After that, the cells were 
washed twice with phosphate-buffered saline 
(PBS) and incubated with 100 μL of 0.5 mg/mL 
MTT for 2 h to measure the cell viability. The 
medium was then discarded, and 100 μL 
dimethyl sulfoxide (DMSO) was added. After 30-
min incubation, absorbance at 570 nm was read 
using a microplate reader. 
 
Evaluation of inhibition of TNF-α and IL-6 
release induced by LPS in vitro 
 
RAW264.7 (1.5×106) were grown in a 48-well 
plate and incubated for 4 h. corynoline (20, 40, 
80 μg/mL) added immediately after addition of 
100 ng/mL LPS. After incubation for another 4 h, 
the supernatants were collected to assess TNF-α 
and IL-6 levels using ELISA kits.  
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Plasma TNF-α and IL-6 levels in LPS-induced 
sepsis mice  
 
A total of 96 ICR mice were randomly divided 
into four groups (n = 24). Group 1 was given LPS 
(2 mg /kg) while groups 2, 3 and 4 were 
respectively given 10, 20 and 40 mg/kg of 
corynoline respectively, followed by injection with 
LPS (2 mg/kg). Four mice were sacrificed at 0, 2, 
4, 8, 12, and 24 h after inception of the 
experiment, and blood samples collected from 
their heart (n = 4). TNF-α and IL-6 levels were 
determined by using ELISA kits. 
 
Survival analysis in mouse model of sepsis 
 
For survival analysis, mice were randomly 
divided into four groups, control group and 
corynoline-treated groups (10, 20, 40 mg/kg). 
Mice were injected i.v. with 15 mg/kg LPS and 
heat-killed E. coli (EC, 1.0 ×1011 CFU/kg). The 
survival rate of mice was observed up to 7 days, 
and each group were 20 mice. The general 
conditions and mice mortalities were observed 




All data were presented as mean ± SD. The Chi-
square test was used to analyze the significance 
of rat mortality differences among groups. All 
other differences in means between two groups 
were analyzed with two-tailed Student’s t-test. 
Results were considered to be statistically 




Structural characteristics of corynoline 
isolated from C. bungeana 
 
The 1H-NMR and 13C-NMR spectra for corynoline 
are shown in Table 1. They indicate good 
agreement with literature data for corynoline 
[7,11]. The structure of the compound is shown 
in Figure 1. 
 
 
Figure 1: Structure of the corynoline isolated from C. 
bungeana 
 
Cytotoxic effect of corynoline on RAW 
264.7cells 
 
To exclude the possibility that the inhibitory 
effects of corynoline on the pro-inflammatory 
cytokines production were due to the cytotoxcity 
of corynoline, MTT assay was performed, and 
when the RAW 264.7 cells were treated with 
corynoline and LPS, there was no obvious 
change in cell viability (Figure 2A). 
 
Effects of corynoline on LPS-induced TNF-α, 
IL-6 levels 
 
Pro-inflammatory cytokines, such as TNF-α, IL-6, 
play important roles in the sepsis process. In the 
results of our present study, corynoline at doses 
of 20, 40 and 80 μg/mL significantly suppressed 
the expressions of TNF-α and IL-6 induced by 
LPS in RAW 264.7 (p < 0.05) (Figure 2B and C).  
 
Effect of corynoline on plasma TNF-α and IL-6 
levels in mice sepsis  
 
As can be seen in Figure 3, after LPS injection, 
the contents of TNF-α and IL-6 were increased, 
and the TNF-α and IL-6 levels peaked 4 h and 8 
h after LPS injection. However, the TNF-α and 
IL-6 levels were significant lower than that in 
 
            Table 1: 1H NMR (600 Hz) and 13 C NMR (150 Hz) data for corynoline in CDCl3 (δ, ppm) 
 
No.    δ H  (J)        δ C      No. δ H  (J) δ C     
1 6.74 (1H, s) 107.7 9 6.91 (1H, d, J=8.1) 110.2 
2  145.1 10 7.04 (1H, d, J=8.0) 118.9 
3  145.2 11 4.07 (1H, s) 76.3 
4 6.76 (1H, s) 112.6 12 3.28 (2H, m) 36.6 
6 3.57, 4.15 (2H, ABq, J=15.0) 54.2 13  40.9 
7  142.7 14 3.43 (1H, s) 70.1 
8  48.1 1a  125.1 
5-N-CH3 2.34 (3H, s) 43.0 4a  127.9 
13-CH3 1.24 (3H, s) 23.3 6a  116.8 
2-O-CH2 6.12 (4H, m). 101.0 10a  136.1 
7-O-CH2  101.4    
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group of LPS used alone at each time points 
after LPS injection (p < 0.05), in a dose-
dependent manner.  
 
Figure 2: Effect of corynoline on TNF-α and IL-6 in 
RAW 264.7 cells induced by LPS. Data are shown and 
expressed as mean ± SD. (n=3). COA means 
corynoline. Asterisks indicated significant difference 
from LPS used alone. *p < 0.05, **p < 0.01.  
 
Effect of corynoline on plasma TNF-α and IL-6 
levels in mice sepsis  
 
As can be seen in Figure 3, after LPS injection, 
the contents of TNF-α and IL-6 were increased, 
and the TNF-α and IL-6 levels peaked 4 h and 8 
h after LPS injection. However, the TNF-α and 
IL-6 levels were significant lower than that in 
group of LPS used alone at each time points 
after LPS injection (p < 0.05), in a dose-
dependent manner. 
 
Corynoline protects mice challenged by lethal 
dose of LPS and heat-killed E. coli  
 
As shown in Figure 4A, 80 % of the mice 
challenged with LPS died within 48 h. However, 
the survival rate of mice treated with corynoline 
was significantly improved, in a dose-dependent 
manner (p < 0.05). In addition, corynoline at the 
dosage of 40 mg/kg exhibited the best protective 
effect with a survival rate of 80%. Furthermore, 
the sepsis model induced by lethal dose of heat-
killed E. coli also demonstrated that the 
corynoline have a notable protective effect 




Natural products isolated from plants are the 
important resource for discovering new, effective 
and safe drugs [12,13]. Currently, lot of active 
monomers, which showed potential anti-septic 
effects, had been found from folk or traditional 
medicinal plants [4,14,15].  
 
LPS is a common trigger of sepsis, and LPS 
stimulates various cells to release lots of 
cytokines such as TNF-α and IL-6. Therefore, 
LPS-induced sepsis model is one of the most 
used and effective methods used to screen anti-
septic drugs [16]. In our present investigation, we 
tested the protective effect of corynoline on 
sepsis induced in mice by a lethal dosage of 
LPS, and found that corynoline has a good 
protective effect in a dose-dependent manner. 
Additionally, since sepsis is commonly induced 
by bacteria-released LPS, a sepsis model using 
heat-killed bacteria is a good approximation of 
clinical sepsis. In our present study, the sepsis 
mice induced by heat-killed E. coli was 
established, and the protective effect of 
corynoline on sepsis was further evaluate; the 
results revealed that the corynoline showed good 
protective effect on sepsis mice. 
 
Sepsis remains one of the leading causes of 
mortality in intensive care units (ICU), and was 
defined as the systemic host responses to 
severe infections and various organisms, viruses 
and fungi [4,17,18]. Host responses to severe 
infection result in the over expressions of pro-
inflammatory mediators such as TNF-α and IL-6. 
TNF-α is one of the key mediators in the initiating 
of systemic inflammatory response, and IL-6 is 
considered as an important later mediator. 
Furthermore, both of the two mediators were 
involved in the activation of cytokine cascade in 
sepsis [19,20]. In our present investigation, we 
examined the effect of corynoline on expressions 
of TNF-α and IL-6 in vivo and in vitro. Our results 
demonstrate that corynoline decreases the 
release of TNF-α and IL-6 induced by LPS in a 
dose-dependent manner, in vivo and in vitro, 
which is likely to be the mechanism of protective 
effect of corynoline in mice sepsis. 
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Figure 3: Effect of corynoline on TNF-α and IL-6 in plasma of LPS-induced sepsis mice. Data are shown and 
expressed as mean ± SD. (n = 4). COA means corynoline. Asterisks indicated significant difference from LPS 
used alone; *p < 0.05, **p < 0.01.  
 
 
Figure 4: Effect of corynoline on the survival rate of mice challenged with lethal dose of LPS and heat-killed E. 
coli. Mice were randomly divided into four groups (n = 20) The mice were observed for 7 days. Asterisks 
indicated significant difference from LPS or heat-killed E. coli used alone; *p < 0.05, **p < 0.01 
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Treatment with corynoline can significantly inhibit 
the mortality of LPS-induced septic mice and the 
mechanism is probably related to the decrease of 
TNF-α and IL-6 releases. The results of our 
present investigation suggest that corynoline can 
be developed as an effective and clinically safe 
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